Nigrostriatal neuronal death in Parkinson's disease - A passive or an active genetically-controlled process?

Journal of Neural Transmission, Supplement

Volumn , Issue 49, 1997, Pages 69-76

  Ziv, I ^a   Barzilai, A ^b   Offen, D ^a   Nardi, N ^b   Melamed, E ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; PROTEIN BCL 2; RECOMBINANT PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; DOPAMINERGIC NERVE CELL; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; NERVE CELL NECROSIS; NEUROPATHOLOGY; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; ANIMAL; BIOSYNTHESIS; CELL STRAIN; CORPUS STRIATUM; GENETICS; NECROSIS; NERVE CELL; PATHOLOGY; PHYSIOLOGY; RAT; SUBSTANTIA NIGRA;

ANIMALS; APOPTOSIS; CORPUS STRIATUM; DOPAMINE; GENES, BCL-2; HUMANS; NECROSIS; NEURONS; PARKINSON DISEASE; PC12 CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RECOMBINANT PROTEINS; SUBSTANTIA NIGRA; TRANSFECTION;

EID: 0030612197     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6844-8_7     Document Type: Review

References (26)

1. Barinaga M (1993) Death gives birth to the nervous system. But how? Science 259: 762-763
2. Boobis AR, Fawthrop DJ, Davies DS (1989) Mechanisms of cell death. Trends Pharmacol Sci 10: 275-280
3. Bursch W, Oberhammer F, Sculte-Hermann R (1992) Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci 13: 245-251
4. Cohen JJ (1993) Apoptosis. Immunol Today 14: 126-130
5. Eastman A (1990) Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2: 275-280
6. Fahn S, Cohen G (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 32: 804-812
7. Garcia I, Martinou I, Tsushimoto Y, Martinou JC (1992) Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 258: 302-304
8. Graham DJ, Tiffany SM, Bell WR, Gutknecht WF (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward c1300 neuroblastoma cells in vitro. Mol Pharmacol 14: 644-653
9. Hirsch EC (1992) Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease? Ann Neurol 32: S88-S93
10. Jenner P, Dexter DT, Sian J (1992) Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. Ann Neurol 32: S82-S87
11. Lin LFH, Doherty DH, Lile JD (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1131-1132
12. Martin DP, Schmidt RE, Distefano PS, Johnson EN (1988) Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by NGF deprivation. J Cell Biol 106: 829-843
13. Michel PP, Hefti F (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J Neurosci Res 26: 428-435
14. Moldeus P, Nordenskjold M, Bolcsfoldi G (1983) Genetic toxicity of dopamine. Mut Res 124: 9-23
15. Olanow CW (1993) A radical hypothesis for neurodegeneration. Trends Neurosci 16: 439-444
16. Orrenius S, Burkitt M, Kass GEN (1992) Calcium ions and oxidative cell injury. Ann Neurol 32: S33-S42
17. Robbins Jh, Otsuka F, Nee LE (1985) Parkinson's disease and Alzheimer's disease: hypersensitivity to x-rays in cultured cell lines. J Neurol Neurosurg Psychiatry 48: 916-923
18. Schraufstatter IU, Hyslop PA, Hinshaw DB (1986) Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly (ADP-ribose) polymerase. Proc Natl Acad Sci 83: 4908-4912
19. Scudiero DA, Tarone RE, Robbins JH (1982) Parkinson's disease and Alzheimer's disease fibroblasts are hypersensitive to killing by MNNG. Clin Res 30: 857(A)
20. Tooyama I, Kawamata T, Walker D, Mcgeer PL (1993) Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease. Neurology 43: 372-376
21. Ueda N, Shah SV (1992) Endonuclease-induced DNA damage and cell death in oxidant injury to renal tubular epithelial cells. J Clin Invest 90: 2593-2597
22. Wick MM (1978) Dopamine: a novel antitumor agent active against B-16 melanoma in vivo. J Invest Dermatol 71: 163-164
23. Wick MM (1980) Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in humsn melanoma. Cancer Res 40: 1414-1418
24. Wick MM (1989) Levodopa/dopamine analogs as inhibitors of DNA synthesis in human melanoma cells. J Invest Dermatol 92: 329S-331S
25. Wyllie AH (1980) Glucocorticocoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-557
26. Ziv I, Melamed E, Nardi N, Luria D, Achiron A, Offen D, Barzilai A (1994) Dopamine induces apoptosis-like cell death in cultured sympathetic neurons - a possible novel pathogenetic mechanism in Parkinson's disease. Neurosci Lett 170: 136-140